Susquehanna International Group, LLP Silverback Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	N/A	214,100 Added 637.2%	247,700 $0
Q2 2024 Aug 15, 2024	BUY	N/A	33,600 New	33,600 $0
Q4 2023 Feb 14, 2024	SELL	N/A	-64,700 Reduced 27.13%	173,800 $0
Q3 2023 Nov 14, 2023	BUY	N/A	206,000 Added 633.85%	238,500 $0
Q2 2023 Aug 11, 2023	BUY	N/A	18,500 Added 132.14%	32,500 $0
Q1 2023 May 16, 2023	BUY	N/A	14,000 New	14,000 $0
Q3 2022 Nov 14, 2022	SELL	$3.91 - $5.52 $965,770 - $1.36 Million	-247,000 Reduced 69.62%	107,800 $569,000

163

62.7M

872K

589K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.